Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.
about
Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseImmunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia.Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women.Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.Perspective for prophylaxis and treatment of cervical cancer: an immunological approach.Pharmacologic activation of the innate immune system to prevent respiratory viral infections.Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:CHuman papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C.Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine.IL-12 secretion by Langerhans cells stimulated with Candida skin test reagent is mediated by dectin-1 in some healthy individuals.Toll-like receptors and genital tract infection.Ubiquitination in host immune response to human papillomavirus infection.Toll-like receptors in human papillomavirus infection.Anti-tumor Activity of Toll-Like Receptor 7 Agonists.T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro.Immunomodulatory Effects of Antimicrobial Drugs.A novel prostate cancer immunotherapy using prostate-specific antigen peptides and skin test reagent as an adjuvant
P2860
Q26996330-EF2B0E05-C03D-4172-9F54-40ECB49B965EQ27307719-DAF1A94A-8448-479A-8161-129FE69B9BC7Q33520407-5DC8491A-0B40-4E63-83A0-F438E9E143F3Q33579661-D0B19FB8-B63F-4017-AE1C-86B2F93CD34FQ33604135-A4EBC980-5C6C-447F-BC4A-1B654462A9E4Q33783092-8C361D4E-8B17-4B9B-9B34-EE636821224CQ34181909-823DF549-EDC9-4E01-82DA-464AD04517A0Q35692082-843FE209-CAB1-47E4-9A1C-0DD4F2A1EAFAQ36315857-72341211-61F6-40B3-BE1E-AAE3CFAA1B52Q36350381-E88FA912-A456-4782-AA5F-B9E66D0DC34FQ37135023-12DAD59D-ED4D-451B-B13B-69E21B6E0826Q37377608-D9FBAA99-0B31-4CB7-A54A-4AA13F5F37E0Q37532916-ECC5649C-939F-4CC6-907D-B62865768E53Q37705702-D734FD8E-E1DC-468B-B37B-C1F1198687C1Q37852608-7362D2E4-D51C-450A-BD44-7BCC21BC27E8Q38084160-0A9F820E-FB89-4756-8BB4-8A18D78CBF17Q39377049-7385F1C7-0E37-4890-8101-20A2AFA7297CQ40673637-D0F80B15-10B5-4CE0-91C5-CD9F65B316D2Q42182822-FCDA7DA5-9145-483B-A5DE-4B9DD3DABCD1Q48146835-2B82206A-0F39-4598-B50A-C6BD8FADBA57Q58732160-3509498A-B8B2-46CA-9517-8B236998414C
P2860
Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reversal of human papillomavir ...... human papillomavirus type 16.
@en
Reversal of human papillomavir ...... human papillomavirus type 16.
@nl
type
label
Reversal of human papillomavir ...... human papillomavirus type 16.
@en
Reversal of human papillomavir ...... human papillomavirus type 16.
@nl
prefLabel
Reversal of human papillomavir ...... human papillomavirus type 16.
@en
Reversal of human papillomavir ...... human papillomavirus type 16.
@nl
P2093
P2860
P356
P1476
Reversal of human papillomavir ...... o human papillomavirus type 16
@en
P2093
Adam B Raff
Diane M Da Silva
Laura M Fahey
P2860
P304
P356
10.4049/JIMMUNOL.0803645
P407
P50
P577
2009-03-01T00:00:00Z